Transaction value governs physician samples sold to distributors; free supplies need documentary verification before excise demand.

Physician samples sold to distributors for an invoice value are valued on transaction value under the Central Excise valuation rules, not by applying MRP-based valuation mechanically where no such basis exists. The text distinguishes free-of-cost distribution, in which no transaction value is available, from genuine sales supported by invoices and other documents. It stresses that the nature of each clearance must be verified item-wise before any demand is recast, because liability depends on proof of sale. Penalties are not sustainable where the underlying valuation and duty liability remain unverified on the documentary record.

---

---

Issues: Whether physician samples sold by the manufacturer to distributors with an invoice value were liable to be assessed on transaction value under Section 4 of the Central Excise Act, 1944, or on the basis applicable to MRP valuation under Section 4A, and whether demand and penalties could be sustained without verification of documentary evidence of such sales.

Analysis: The dispute turned on whether the goods were in fact sold to distributors or were merely cleared free of cost. Where physician samples are sold and a transaction value exists, that value cannot be ignored merely because the goods are described as physician samples. The reasoning distinguished cases where samples are distributed free of cost and therefore have no transaction value. The record also required factual verification of the invoices and supporting documents to determine whether the assessee had actually sold the samples or whether the clearances were free supplies. On this basis, the demand could not be uniformly recast under Section 4A without first verifying the nature of the clearances. Since the assessee's liability depended on proof of sale, the adjudicating authority was required to examine the documentary evidence item-wise. Penalties could not survive independently in the circumstances.

Conclusion: Physician samples sold to distributors are to be valued on the basis of the transaction value, not by applying Section 4A mechanically. The demand was set aside to the extent the assessee could substantiate sales with documents, the balance demand was sustained subject to verification, and all penalties were set aside.

---